Federal Register / Vol. 65, No. 93 / Friday, May 12, 2000 / Notices 30613

General and the Federal Trade

Commission disclosing (1) the identities

of the parties and (2) the nature and

objectives of the venture. The

notifications were filed for the purpose

of invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specified

circumstances. Pursuant to section 6(b)

of the Act, the identities of the parties

are United Technologies Corporation

(‘‘UTC’’), Hartford, CT; and i2 Federal,

Inc., Irving, TX. The nature and

objectives of the venture are to engage

in cooperative research and

development in the area of Open

Software Tools for Condition Based

Maintenance pursuant to an Advanced

Technology Program with the National

Institute of Standards and Technology.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 00–12048 Filed 5–11–00; 8:45 am]

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Water Heater Industry

Joint Research and Development

Consortium

Notice is hereby given that, on

December 3, 1999, pursuant to Section

6(a) of the National Cooperative

Research and Production Act of 1993,

15 U.S.C. 4301 et seq. (‘‘the Act’’), the

Water Heater Industry Joint Research

and Development Consortium (‘‘the

Consortium’’) has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing changes in its

membership status. The notifications

were filed for the purpose of extending

the Act’s provisions limiting the

recovery of antitrust plaintiffs to actual

damages under specified circumstances.

Specifically, A. O. Smith Water

Products Company, a division of A.O.

Smith Corporation, Irving, TX has been

added as a party to this venture.

No other changes have been made in

either the membership or planned

activity of the group research project.

Membership in this group research

project remains open, and the

Consortium intends to file additional

written notification disclosing all

changes in membership.

On February 28, 1995, the Consortium

filed its original notification pursuant to

Section 6(a) of the Act. The Department

of Justice published a notice in the

Federal Register pursuant to Section

6(b) of the Act on March 27, 1995 (60

FR 15789).

The last notification was filed with

the Department on March 17, 1999. A

notice was published in the Federal

Register pursuant to Section 6(b) of the

Act on October 1, 1999 (64 FR 53416).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 00–12039 Filed 5–11–00; 8:45 am]

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Danilo Abud-Sanchez, M.D.;

Revocation of Registration

On August 5, 1999, the Deputy

Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration (DEA) issued an Order

to Show Cause to Danilo Abud-Sanchez,

M.D., of Paramount, California,

notifying him of an opportunity to show

cause as to why DEA should not revoke

his DEA Certificate of Registration

BA3042657 pursuant to 21 U.S.C.

824(a)(3), and deny any pending

applications for renewal of his

registration pursuant to 21 U.S.C. 823(f),

for reason that he is not currently

authorized to handle controlled

substances in the State of California.

The order also notified Dr. AbudSanchez that should no request for a

hearing be filed within 30 days, his

hearing right would be deemed waived.

DEA first sent the Order to Show

Cause to Dr. Abud-Sanchez at his

registered location, and it was returned

unclaimed. Next, the Order to Show

Cause was sent to Dr. Abud-Sanchez at

a residential address, and it too was

returned unclaimed. DEA investigators

then contacted Dr. Abud-Sanchez’ legal

counsel who indicated that he would

accept service of the Order to Show

Cause on behalf of Dr. Abud-Sanchez.

The Order to Show Cause was sent to

Dr. Abud-Sanchez’ legal counsel and

DEA received a signed receipt

indicating that the Order to Show Cause

was received on October 25, 1999.

No request for a hearing or any other

reply was received by DEA from Dr.

Abud-Sanchez or anyone purporting to

represent him in this matter. Therefore,

the Deputy Administrator, finding that

(1) 30 days have passed since the receipt

of the Order to Show Cause, and (2) no

request for a hearing having been

received, concludes that Dr. AbudSanchez is deemed to have waived his

hearing right. After considering material

from the investigative file in this matter,

the Deputy Administrator now enters

his final order without a hearing

pursuant to 21 CFR 1301.43(d) and (e)

and 1301.46.

The Deputy Administrator finds that

Dr. Abud-Sanchez currently possesses

DEA Certificate of Registration

BA3042657 issued to him in California.

The Deputy Administrator further finds

that effective February 17, 1997, the

Medical Board of California revoked Dr.

Abud-Sanchez’ license to practice

medicine. Dr. Abud-Sanchez did not

present any evidence that his medical

license has since been reinstated in

California and there is no such evidence

in the investigative file. Therefore, the

Deputy Administrator finds that Dr.

Abud-Sanchez is not currently

authorized to practice medicine in the

State of California and as a result, it is

reasonable to infer that he is also not

authorized to handle controlled

substances in that state.

The DEA does not have the statutory

authority under the Controlled

Substances Act to issue or maintain a

registration if the applicant or registrant

is without state authority to handle

controlled substances in the state in

which he conducts his business. See

U.S.C. 802(21), 832(f) and 824(a)(3).

This prerequisite had been consistencly

upheld. See Romeo. J. Perez, M.D., 62

FR 16,193 (1997); Demetris A. Green,

M.D., 61 FR 70,728 (1996); Domminick

A. Ricci, M.D., 58 FR 51,104 (1993).

Here it is clear that Dr. Abud-Sanchez

is not currently authorized to handle

controlled substances in the State of

California. As a result, he is not entitled

to a DEA registration in that state.

Accordingly, the Deputy

Administrator of the Drug Enforcement

Administration, pursuant to the

authority vested in him by 21 U.S.C. 823

and 824 and 28 CFR 0.100(b) and 0.104,

hereby orders that DEA Certificate of

Registration BA3042657, previously

issued to Danilo Abud-Sanchez, M.D.,

be, and it hereby is, revoked. The

Deputy Administrator further orders

that any pending applications for the

renewal of such registration, be, and

they hereby are, denied. This order is

effective June 12, 2000.

Dated: May 4, 2000.

Donnie R. Marshall,

Deputy Administrator.

[FR Doc. 00–11887 Filed 5–11–00; 8:45 am]

BILLING CODE 4410–09–M